Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Zivanovic

Showing results (41-50 of 204) with videos related to

Pageof 21
Sort By:
Gynecologic Oncology|July 8, 2019
Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancerKoji Matsuo, Yongmei Huang, Oliver Zivanovic, et al.
Archives of Gynecology and Obstetrics|May 16, 2023
Prognostic factors in undifferentiated uterine sarcoma: a subanalysis of the SARCUT studyRonalds Macuks, Yusuf Yildirim, Rosanna Mancari, et al.
Gynecologic Oncology|May 12, 2024
Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary studyOlga T Filippova, Katherine Boecking, Vance Broach, et al.
Gynecologic Oncology|November 19, 2023
Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterusYu Hui Lim, Christian Dagher, Nadeem R Abu-Rustum, et al.
The American Journal of Surgical Pathology|April 15, 2011
Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirusKay J Park, Takako Kiyokawa, Robert A Soslow, et al.
Gynecologic Oncology Reports|February 11, 2022
Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancerRami Vanguri, Jamal Benhamida, Jonathan H Young, et al.
Annals of Surgical Oncology|December 29, 2022
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2)Stephanie N Gregory, Carrie E Ryan, Jonathan M Hernandez, et al.
Gynecologic Oncology|May 19, 2016
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization centerBrooke A Schlappe, Jennifer J Mueller, Oliver Zivanovic, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 31, 2021
Ovarian cancer recurrence detection may not require in-person physical examination: an MSK team ovary studyJacqueline Feinberg, Karen Carthew, Emily Webster, et al.
Gynecologic Oncology|August 7, 2016
Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18]Brooke A Schlappe, Jennifer J Mueller, Oliver Zivanovic, et al.
Pageof 21

Showing results (41-50 of 204) with videos related to

Sort By:
Pageof 21
Gynecologic Oncology|July 8, 2019
Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancerKoji Matsuo, Yongmei Huang, Oliver Zivanovic, et al.
Archives of Gynecology and Obstetrics|May 16, 2023
Prognostic factors in undifferentiated uterine sarcoma: a subanalysis of the SARCUT studyRonalds Macuks, Yusuf Yildirim, Rosanna Mancari, et al.
Gynecologic Oncology|May 12, 2024
Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary studyOlga T Filippova, Katherine Boecking, Vance Broach, et al.
Gynecologic Oncology|November 19, 2023
Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterusYu Hui Lim, Christian Dagher, Nadeem R Abu-Rustum, et al.
The American Journal of Surgical Pathology|April 15, 2011
Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirusKay J Park, Takako Kiyokawa, Robert A Soslow, et al.
Gynecologic Oncology Reports|February 11, 2022
Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancerRami Vanguri, Jamal Benhamida, Jonathan H Young, et al.
Annals of Surgical Oncology|December 29, 2022
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2)Stephanie N Gregory, Carrie E Ryan, Jonathan M Hernandez, et al.
Gynecologic Oncology|May 19, 2016
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization centerBrooke A Schlappe, Jennifer J Mueller, Oliver Zivanovic, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 31, 2021
Ovarian cancer recurrence detection may not require in-person physical examination: an MSK team ovary studyJacqueline Feinberg, Karen Carthew, Emily Webster, et al.
Gynecologic Oncology|August 7, 2016
Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18]Brooke A Schlappe, Jennifer J Mueller, Oliver Zivanovic, et al.
Pageof 21